AKT1 and colorectal carcinoma: This study was designed to identify players that mediate the interaction between PI3K/Akt and Wnt/β-catenin pathways or mutational alterations that might be useful in predicting responses to treatment using modulators of these pathways and to determine their viability as therapeutic targets for CRC treatment.